Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Parsons

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
The Australian Journal of Experimental Biology and Medical Science|December 1, 1986
Accumulation of chlorpromazine and thiouracil by human melanoma cells in cultureP G Parsons, B J Allen
The Australian Journal of Experimental Biology and Medical Science|December 1, 1979
Effects of thymidine analogues on murine and human cellsS G Smellie, P G Parsons
Melanoma Research|January 26, 1999
Inhibition of Ku autoantigen binding activity to the E2F motif after ultraviolet B irradiation of melanocytic cellsJ Pedley, A Pettit, P G Parsons
Biochemical Pharmacology|February 15, 1990
Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell linesP Musk, A Stowers, P G Parsons
International Journal of Cancer|October 15, 1976
Survey of human lymphoblastoid cell lines and primary cultures of normal and leukaemic leukocytes for oncornavirus productionE Klucis, L Jackson, P G Parsons
Biotechniques|February 24, 2001
Cost-efficient quantification of enzyme-linked immunospotM Bharadwaj, P G Parsons, D J Moss
Histopathology|March 1, 1991
Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibodyH Takahashi, G M Strutton, P G Parsons
Cancer Research|May 1, 1989
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximineE P Kable, D Favier, P G Parsons
The Journal of Investigative Dermatology|April 1, 1988
Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cellsM McEwan, P G Parsons, D J Moss
International Journal of Cancer|May 15, 1974
Detection in human melanoma cell lines of particles with some properties in common with RNA tumour virusesP G Parsons, P Goss, J H Pope
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
The Australian Journal of Experimental Biology and Medical Science|December 1, 1986
Accumulation of chlorpromazine and thiouracil by human melanoma cells in cultureP G Parsons, B J Allen
The Australian Journal of Experimental Biology and Medical Science|December 1, 1979
Effects of thymidine analogues on murine and human cellsS G Smellie, P G Parsons
Melanoma Research|January 26, 1999
Inhibition of Ku autoantigen binding activity to the E2F motif after ultraviolet B irradiation of melanocytic cellsJ Pedley, A Pettit, P G Parsons
Biochemical Pharmacology|February 15, 1990
Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell linesP Musk, A Stowers, P G Parsons
International Journal of Cancer|October 15, 1976
Survey of human lymphoblastoid cell lines and primary cultures of normal and leukaemic leukocytes for oncornavirus productionE Klucis, L Jackson, P G Parsons
Biotechniques|February 24, 2001
Cost-efficient quantification of enzyme-linked immunospotM Bharadwaj, P G Parsons, D J Moss
Histopathology|March 1, 1991
Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibodyH Takahashi, G M Strutton, P G Parsons
Cancer Research|May 1, 1989
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximineE P Kable, D Favier, P G Parsons
The Journal of Investigative Dermatology|April 1, 1988
Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cellsM McEwan, P G Parsons, D J Moss
International Journal of Cancer|May 15, 1974
Detection in human melanoma cell lines of particles with some properties in common with RNA tumour virusesP G Parsons, P Goss, J H Pope
Pageof 14